sur OXURION (EBR:OXUR)
Oxurion Publishes its 2024 Annual Report and Convenes its General Meeting
Leuven, Belgium – April 11, 2025 – Oxurion NV, a company listed on Euronext Brussels under the symbol OXUR, specializing in the development of ophthalmic therapies, has published its annual report for the financial year ending December 31, 2024. This document is available in the "Investors" section of the company's website and can be downloaded in PDF format.
In addition, Oxurion has convened its Annual General Meeting of Shareholders. Documents relating to this meeting are available on the company's website, in the "Shareholders' Meetings" section.
Oxurion cautions against forward-looking statements included in this press release, which involve risks and uncertainties. The company assumes no obligation to update these statements in light of new information or future events.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de OXURION